ClinicalTrials.gg
CompletedNCT03087734Updated Oct 12, 2021

Evaluation of a New Model of Metallic Bar and Stabilizer for Use in MIRPE

An interventional study of Implantation of new model of bar with oblique stabilizers and Implantation of regular bar with perpendicular stabilizers in Funnel Chest, sponsored by University of Sao Paulo. Completed at 1 site in Brazil. Open to participants aged 10 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-10-12.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
10 Years and older
Sex
All
01

Study summary

Pectus excavatum (PE) is the most common deformity of the chest wall, occurring in approximately 1/1000 people. Currently, surgical treatment by minimally invasive technique is consolidating as preferred technique for the treatment of this condition. In this technique a metal bar is inserted in retrosternal position, pushing the sternum without the necessity of resecting the condral cartilages. Despite the advantages obtained with this technique, it is not without complications and the displacement of the bar is one of the most important. In order to minimize this problem we developed a new model of stabilizers, as well as all necessary instruments for performing minimally invasive surgery. The aim of this study is to compare two surgical groups, one making use of the new oblique stabilizer compared to the conventional perpendicular stabilizer to determine which one has less displacement. Furthermore, this study also aims to assess the full range of instruments developed by a national company, to carry out this type of surgery, which has cost compatible with our economic reality, and that can be accessible to our Public Health patients.

Read the detailed description

Introduction Pectus excavatum (PE) is presented as a sunken sternum in the midline and these chest deformities are not uncommon, occurring in approximately 1/1000.

It is commonly accepted that the abnormal growth of condral cartilage results in displacement of the sternum. Most patients and their parents seek medical advice for psychosocial concerns, particularly related to the cosmetic aspects and the consequent aversion to sports or public exposure. Physiological tests are often normal, but both the cardiac index and pulmonary function may be affected.

Surgical treatment of pectus excavatum Nuss broke the paradigm in PE surgery with the publication of their results using a technique called minimally invasive. This technique involves lateral incisions in the chest and the placement of one or two temporary steel bars, which are shaped during surgery, specifically for each patient. These bars are placed in retrosternal position and the sternum is elevated without the need of cartilage resection.

This surgical technique, in addition to the bars and stabilizers, needs a set of instruments that are used in the customization of the bar for each patient and, after three years, the withdrawal of the bar at the end of the treatment.

Another problem refers to the displacement of the metallic bars that are positioned under the sternum and that are held in position by placing stabilizers, one at each lateral end of the bar. These stabilizers, which are perpendicular to the bar, has the function to expand its area of contact with the chest wall in order to prevent it from moving from its position.

In order to increase the stability of the bar, preventing their movement, various modifications have been proposed. The investigators believe that further modification can be introduced. If the stabilizer metal bar has an oblique position relative to the bar (rather than perpendicular as it is currently) it will be perpendicular to the ribs, thus increasing its area of contact with the chest wall, which might bring more stability.

The investigators are also proposing that the new metal bar that is being developed is completely smooth, not having the usual slots that the current model has at the extremities of the bars. The reason for this is to try to prevent bleeding during bars withdrawal after 3 years of use.

Another proposed amendment is a pressure screw incorporated into the stabilizer itself.

Search object The object of research is the development of a new model of metallic bar and stabilizers, as well as dedicated surgical instruments whose purpose is to perform minimally invasive repairs of PE.

Social relevance One of the reasons why the Public Health in Brazil gives no coverage for this type of surgical treatment for patients with PE is the high cost of surgical equipment that is imported. The development of this material in the country, as is being proposed in this project, has high social relevance that may represent savings by avoiding the purchase of imported material and the possibility of making available this type of surgical treatment for patients served by our public health.

Site of the search The research will be performed in the Department of Thoracic Surgery, Heart Institute (InCor) of the Hospital das Clinicas, Faculty of Medicine, University of São Paulo.

02

Conditions studied

  • Funnel Chest

Browse trials for

Keywords

  • Prostheses and Implants
03

In context

Funnel Chest

79 studies on the registry are indexed under Funnel Chest; 10 are open to participants now.

This study's enrollment of 30 is below the median of 40 across 46 interventional studies indexed under Funnel Chest.

Browse Funnel Chest studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,035 studies on the registry; 95 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pectus excavatum patients

Exclusion criteria

Exclusion Criteria:

  • Presence of complex congenital anomalies;
  • Retardation neurodevelopment;
  • Congenital heart disease;
  • Chronic .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Perpendicular stabilizer

    Implantation of regular bar with perpendicular stabilizers

    Device: Implantation of regular bar with perpendicular stabilizers

  • Experimental
    Oblique stabilizer

    Implantation of new model of bar with oblique stabilizers

    Device: Implantation of new model of bar with oblique stabilizers

Interventions

  • DeviceImplantation of new model of bar with oblique stabilizers

    Implantation of new model of bar with oblique stabilizers

  • DeviceImplantation of regular bar with perpendicular stabilizers

    Implantation of regular bar with perpendicular stabilizers

06

What researchers measure

Primary outcomes

  1. Grade of metallic bar dislodgment measured through Rx images

    The grade of metallic bar dislodgment will be measured through the comparison of the Rx taken in patient follow up in terms of: a) bar flipping; b) lateral sliding and c) hinge-point disruption

    Time frame: One year

07

Study locations

1 site
  • Heart Institute (InCor) Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
    Sao Paulo, SP, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2017 to primary completion in Sep 2018, 11 months.

Of 31 interventional studies with no phase under Funnel Chest, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 68. This study's 11 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2016
First posted
Mar 22, 2017
StartActual
Oct 3, 2017
Primary completionActual
Sep 25, 2018
CompletionActual
Mar 1, 2019
Last update
Oct 12, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03087734
Collaborators
Fundação de Amparo à Pesquisa do Estado de São Paulo
Responsible party
Miguel L. Tedde (Principal Investigator, University of Sao Paulo) — Principal investigator
First posted
Mar 22, 2017
Start date
Oct 3, 2017
Primary completion
Sep 25, 2018
Completion
Mar 1, 2019
Last update
Oct 12, 2021

Study contacts

Paulo M Pego-Fernandes
study chair · Heart Institute (InCor), Hospital das Clinicas, University of Sao Paulo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion